Charles W. Francis, M.D.

Charles W. Francis, M.D.

Contact Information

University of Rochester Medical Center
School of Medicine and Dentistry
601 Elmwood Ave, Box 610
Rochester, NY 14642

Office: (585) 275-5823
Fax: (585) 273-5761
Administrative: (585) 275-3761

Journal Articles

Showing all 195 journal articles available.

2014
Spinelli, Sherry L; Lannan, Katie L; Casey, Ann E;Croasdell, Amanda; Curran, Timothy M; Henrichs, Kelly F; Pollock, Stephen J; Milne, Ginger A; Refaai, Majed A; Francis, Charles F; Phipps, Richard P; Blumberg, Neil. "Isoprostane and isofuran lipid mediators accumulate in stored red blood cells and influence platelet function in vitro". Blood Components. 2014; 54: 1569-1579.
2013 May
Lyman, GH; Khorana, AA; Kuderer, NM; Lee, AY; Arcelus, JI; Balaban, EP; Clarke, JM; Flowers, CR; Francis,CW; Gates, LE; Kakkar, AJ; Key, NS; Levine, MN; Liebman, HA; Tempero, MA; Wong, SL; Prestrud, AA; Falanga, A. "Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Practice Guideline Update." Journal of Clinical Oncology. 2013; . Link
2013 Apr
Francis CW. "Prevention of VTE in patients having major orthopedic surgery." Journal of thrombosis and thrombolysis. 2013 Apr; 35(3):359-67.
2013 Feb
Refaai MA, Carter J, Henrichs KF, Davidson DC, Pollock SJ, Casey AE, Spinelli SL, Phipps RP, Francis CW, Blumberg N. "Alterations of platelet function and clot formation kinetics after in vitro exposure to anti-A and -B." Transfusion. 2013 Feb; 53(2):382-93. Epub 2012 May 25.
2013
Connolly, G; Menapace, L; Safadjou, S; Francis, CW; Khorana, A. "Prevalence and clinical significance of incidental and clinically suspected venous thromboembolism in lung cancer patients." Clinical Lung cancer. 2013; : In Press.
2013
Kuderer, NM; Culakova, E; Lyman, GH; Francis, C; Falanga, A; Khorana, AA. "A Validated Risk Score for VTE is Predictive Of Early Cancer Progression and Mortality". Journal of Clinical Oncology - Submitted. 2013; .
2013
Spinelli, SL; Lannan, KL; Case, AE; Croasdell, A; Curran, TM; Henrichs, KF; Pollock, SJ; Refaai, MA; Francis, CW; Milne, GA; Phipps, RP; Blumberg, N. "Isoporstane and isofuran lipid mediators accumulate in stored red blood cell concentrates and influence platelet function in vitro". Transfusion. 2013; .
2013
Spinelli, SL; Lannan, KL; Casey, AE; Croasdell, A; Curran, TM; Henrichs, KF; Pollock, SJ; Milne, GA; Refaai, MA; Francis, CW; Phipps, P and Blumberg, N. "Isoprostane and isofuran lipid mediators accumulate in stored red blood cells and influence platelet function in vitro". Transfusion. 2013; [Epub ahead of print].
2012 Oct
Gudmundsdottir BR, Francis CW, Bjornsdottir AM, Nellbring M, Onundarson PT. "Critical role of factors II and X during coumarin anticoagulation and their combined measurement with a new Fiix-prothrombin time." Thrombosis research. 2012 Oct; 130(4):674-81. Epub 2012 Jan 04.
2012 Aug
Hackney DN, Miller RK, Pressman EK, Francis CW, Simhan HN. "Vaginal bleeding in early pregnancy and circulating markers of thrombin generation." The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 2012 Aug; 25(8):1479-82. Epub 2012 Jan 24.
2012 Jun
Mongan J, Mieszczanska HZ, Smith BH, Messing SP, Phipps RP, Francis CW. "Pioglitazone inhibits platelet function and potentiates the effects of aspirin: a prospective observation study." Thrombosis research. 2012 Jun; 129(6):760-4. Epub 2012 Jan 04.
2012 Feb
Guyatt GH, Eikelboom JW, Gould MK, Garcia DA, Crowther M, Murad MH, Kahn SR, Falck-Ytter Y, Francis CW, Lansberg MG, Akl EA, Hirsh J. "Approach to outcome measurement in the prevention of thrombosis in surgical and medical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines." Chest. 2012 Feb; 141(2 Suppl):e185S-94S.
2012 Feb
Falck-Ytter Y, Francis CW, Johanson NA, Curley C, Dahl OE, Schulman S, Ortel TL, Pauker SG, Colwell CW. "Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines." Chest. 2012 Feb; 141(2 Suppl):e278S-325S.
2011 Jul
Refaai MA, Fialkow LB, Heal JM, Henrichs KF, Spinelli SL, Phipps RP, Masel E, Smith BH, Corsetti JP, Francis CW, Bankey PE, Blumberg N. "An association of ABO non-identical platelet and cryoprecipitate transfusions with altered red cell transfusion needs in surgical patients." Vox sanguinis. 2011 Jul; 101(1):55-60. Epub 2011 Mar 18.
2011 Mar 3
Moss AJ, Francis CW, Ryan D. "Collaborative clinical trials." The New England journal of medicine. 2011 Mar 3; 364(9):789-91.
2011
Refaai, MA; Henrichs, KF; Spinelli, SL; Phipps, RP; Masel, E; Smith, BH; Francis, CW; Blumberg, N. "Platelet Activation Following Exposure to Anti-ABO Antibodies-An In Vitro Study." US Oncology & Hematology. 2011; 7(1): 72-4.
2010 Aug
Connolly GC, Khorana AA, Kuderer NM, Culakova E, Francis CW, Lyman GH. "Leukocytosis, thrombosis and early mortality in cancer patients initiating chemotherapy." Thrombosis research. 2010 Aug; 126(2):113-8.
2010 Jul
Candelario GD, Francis CW, Panzer R, McAdam KS, Cockrell D, Baird T, Khorana AA. "A computerized prompt for thromboprophylaxis in hospitalized cancer patients." Thrombosis research. 2010 Jul; 126(1):32-4. Epub 2009 Oct 30.
2010 Mar
Spinelli SL, Casey AE, Pollock SJ, Gertz JM, McMillan DH, Narasipura SD, Mody NA, King MR, Maggirwar SB, Francis CW, Taubman MB, Blumberg N, Phipps RP. "Platelets and megakaryocytes contain functional nuclear factor-kappaB." Arteriosclerosis, thrombosis, and vascular biology. 2010 Mar; 30(3):591-8. Epub 2009 Dec 30.
2009 Nov
Bernard JJ, Seweryniak KE, Koniski AD, Spinelli SL, Blumberg N, Francis CW, Taubman MB, Palis J, Phipps RP. "Foxp3 regulates megakaryopoiesis and platelet function." Arteriosclerosis, thrombosis, and vascular biology. 2009 Nov; 29(11):1874-82. Epub 2009 Aug 06.
2009 Oct 10
Francis CW. "Prevention of venous thromboembolism in hospitalized patients with cancer." Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009 Oct 10; 27(29):4874-80. Epub 2009 Aug 24.
2009 Oct 10
Kuderer NM, Ortel TL, Francis CW. "Impact of venous thromboembolism and anticoagulation on cancer and cancer survival." Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009 Oct 10; 27(29):4902-11. Epub 2009 Sep 08.
2009 Sep
Brummel-Ziedins KE, Gissel M, Francis C, Queenan J, Mann KG. "The effect of high circulating estradiol levels on thrombin generation during in vitro fertilization." Thrombosis research. 2009 Sep; 124(4):505-7. Epub 2009 Mar 17.
2009 Jul
Sandset PM, Francis C. "Thrombosis Research: Introduction of e-pages." Thrombosis research. 2009 Jul; 124(3):251.
2009 May
Yao JL, Ryan CK, Francis CW, Kohli M, Taubman MB, Khorana AA. "Tissue factor and VEGF expression in prostate carcinoma: a tissue microarray study." Cancer investigation. 2009 May; 27(4):430-4.
2009 May
Springer D, Miller J, Spinelli S, Pasa-Tolic L, Purvine S, Daly D, Zangar R, Jin S, Blumberg N, Francis C, Taubman M, Casey A, Wittlin S, Phipps R. "Platelet proteome changes associated with diabetes and during platelet storage for transfusion." Journal of proteome research. 2009 May; 8(5):2261-72.
2009
Blumberg N, Spinelli SL, Francis CW, Taubman MB, Phipps RP. "The platelet as an immune cell-CD40 ligand and transfusion immunomodulation." Immunologic research. 2009 45(2-3):251-60. Epub 2009 Jan 29.
2008 Nov 24
Khorana AA, Francis CW, Blumberg N, Culakova E, Refaai MA, Lyman GH. "Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer." Archives of internal medicine. 2008 Nov 24; 168(21):2377-81.
2008 Nov
Khorana AA, Francis CW, Menzies KE, Wang JG, Hyrien O, Hathcock J, Mackman N, Taubman MB. "Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer." Journal of thrombosis and haemostasis : JTH. 2008 Nov; 6(11):1983-5. Epub 2008 Sep 15.
2008 May 15
Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW. "Development and validation of a predictive model for chemotherapy-associated thrombosis." Blood. 2008 May 15; 111(10):4902-7. Epub 2008 Jan 23.
2008 Jan
Sahni A, Simpson-Haidaris PJ, Sahni SK, Vaday GG, Francis CW. "Fibrinogen synthesized by cancer cells augments the proliferative effect of fibroblast growth factor-2 (FGF-2)." Journal of thrombosis and haemostasis : JTH. 2008 Jan; 6(1):176-83. Epub 2007 Oct 22.
2008 Jan
Ray DM, Spinelli SL, Pollock SJ, Murant TI, O'Brien JJ, Blumberg N, Francis CW, Taubman MB, Phipps RP. "Peroxisome proliferator-activated receptor gamma and retinoid X receptor transcription factors are released from activated human platelets and shed in microparticles." Thrombosis and haemostasis. 2008 Jan; 99(1):86-95.
2008
O'Brien JJ; Spinelli S; Tober J; Blumberg N; Francis CW; Taubman M;. "15-deoxy-&d12, 14-PGJ2 enhances platelet production from megakaryocytes". Blood. 2008; .
2008
Ginsberg JS; Davidson BL; Comp PC; Francis CW; Friedman RJ; Hyo MH; Lieberman J; Muntz JE; Raskob GE; Clements ML; Hantel S; Schnee JM; Caprini JA for the RE-MOBILIZE Study Group. "The oral thrombin inhibitor debigatran etexilate vs the North American enoxaparin regimen for the prevention of venous thromboembolism after knee replacement surgery: the RE-MOBILIZE trial". J Arthroplasty. 2008; .
2008
Francis CW. "Warfarin: an historical perspective." Hematology. 2008 :251.
2008
Francis CW. "New issues in oral anticoagulants." Hematology. 2008 :259-65.
2007 Nov 15
Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH. "Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients." Cancer. 2007 Nov 15; 110(10):2339-46.
2007 May 15
Khorana AA, Ahrendt SA, Ryan CK, Francis CW, Hruban RH, Hu YC, Hostetter G, Harvey J, Taubman MB. "Tissue factor expression, angiogenesis, and thrombosis in pancreatic cancer." Clinical cancer research : an official journal of the American Association for Cancer Research. 2007 May 15; 13(10):2870-5.
2007 May
Mieszczanska H, Kaba NK, Francis CW, Gerich JE, Dodis R, Schwarz KQ, Phipps RP, Smith BH, Lee M, Messing S, Taubman MB. "Effects of pioglitazone on fasting and postprandial levels of lipid and hemostatic variables in overweight non-diabetic patients with coronary artery disease." Journal of thrombosis and haemostasis : JTH. 2007 May; 5(5):942-9.
2007 Mar
Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH. "Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy." Journal of thrombosis and haemostasis : JTH. 2007 Mar; 5(3):632-4.
2007
Kuderer NM; Khorana AA; Lyman GH; Francis CW. "A Meta-Analysis and Systematic Review of the Efficacy and Safety of Anticoagulants as Cancer Treatment: Impact on survival and Bleeding Complications". Cancer. 2007; 5: 1149-1161.
2006
Khorana AA; Francis CW; Culakova E; Fisher RI; Kuderer N; Lyman GH. "Thromboembolism in hospitalized neutropenic cancer patients". J Clin Oncol. 2006; . Link
2006
Blumberg N; Francis CW; Heal J. "Clinical Use of Plasma and Plasma Fractions". Baillier's Best Practice & Research: Clinical Haematology. 2006; . Link
2005 Jun
Rozmus G, Daubert JP, Huang DT, Rosero S, Hall B, Francis C. "Venous thrombosis and stenosis after implantation of pacemakers and defibrillators." Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing. 2005 Jun; 13(1):9-19.
2005
Khorana AA, Francis CW, Culakova E, Lyman GH. "Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study." Cancer. 2005 104(12):2822-9.
2005
Sahni A; Sahni S; Francis CW. "Stimulation of endothelial cell proliferation by FGF-2 in the presence of fibrinogen requires avB3." ATVB. 2005; . Link
2005
Fiessinger JN; Huisman MV; Davidson BL; Bounameaux H; Francis CW. "Ximelagatran vs. low molecular weight heparin and warfarin for the treatment of deep vein thrombosis: a randomized controlled trial". JAMA. 2005; . Link
2005
Sahni A; Khorana AA; Baggs RB; Peng H; Francis CW. "FGF-2 binding to fibrin(ogen) is required for augmented angiogenesis". Blood. 2005; . Link
2004 May
Kaba NK, Francis CW, Moss AJ, Zareba W, Oakes D, Knox KL, Fernández ID, Rainwater DL, . "Effects of lipids and lipid-lowering therapy on hemostatic factors in patients with myocardial infarction." Journal of thrombosis and haemostasis : JTH. 2004 May; 2(5):718-25.
2004 Apr
Altland OD, Dalecki D, Suchkova VN, Francis CW. "Low-intensity ultrasound increases endothelial cell nitric oxide synthase activity and nitric oxide synthesis." Journal of thrombosis and haemostasis : JTH. 2004 Apr; 2(4):637-43.
2004 Mar 15
Peng H, Sahni A, Fay P, Bellum S, Prudovsky I, Maciag T, Francis CW. "Identification of a binding site on human FGF-2 for fibrinogen." Blood. 2004 Mar 15; 103(6):2114-20. Epub 2003 Nov 20.
2004
Francis CW; Berkowitz SD; Comp PC. "Comparison of the Oral Direct Thrombin Inhibitor Ximelagatran with Warfarin for the Prevention of Venous Thromboembolism Following total Knee Replacement". NEJM. 2004; 349: 1703-1712. Link
2004
Sahni A; Guo M; Sahni SK; Francis CW. "Interluekin-1B but not IL-1a Binds t Fibrinogen and Fibrin and has Enhanced Activity in the Bound Form". Blood. 2004; . Link
2004
Sahni A; Sahni SK; Simpson-Haidaris PJ; Francis CW. "Fibrinogen binding potentiates FGF-2 but not VEGF induced expression of uPA, uPAR, and PAI-1 in endothelial cells." J Thromb Haemost. 2004; . Link
2004
Akbiyik F; Ray DM; Gettings KF; Blumberg N; Francis CW and Phipps RP;. "Human bone marrow megakaryocytes and platelets express PPARy and PPARy agonists blunt platelet release of CD40 ligand and thromboxanes". Blood. 2004; . Link
2004
Guo M; Sahni SK; Sahni A; Francis CW;. "Fibrinogen regulates the expression of inflammatory chemokines through NF-kB activation of endothelial cells". J Thromb Haemost. 2004; . Link
2004
Siegel RJ; Suchkova VN; Miyamoto T; Luo H; Baggs RB; Neuman Y; Horzewski M; Francis CW; et al. "Ultrasound Energy Improves Myocardial Perfusion in the Presence of Coronary Occlusion". JACC. 2004; . Link
2003 Nov 1
Khorana AA, Sahni A, Altland OD, Francis CW. "Heparin inhibition of endothelial cell proliferation and organization is dependent on molecular weight." Arteriosclerosis, thrombosis, and vascular biology. 2003 Nov 1; 23(11):2110-5. Epub 2003 Aug 14.
2003 Jun
Sahni A, Francis CW. "Plasmic degradation modulates activity of fibrinogen-bound fibroblast growth factor-2." Journal of thrombosis and haemostasis : JTH. 2003 Jun; 1(6):1271-7.
2003 Jan
Gottlieb RH, Voci SL, Syed L, Shyu C, Fultz PJ, Rubens DJ, Strang JG, Carson N, DiGrazio WJ, Francis CW. "Randomized prospective study comparing routine versus selective use of sonography of the complete calf in patients with suspected deep venous thrombosis." AJR. American journal of roentgenology. 2003 Jan; 180(1):241-5.
2003
Joshi S; Francis CW; Silverman DJ; Sahni S. "Nuclear Factor kB protects against Host Cell Apoptosis during Rickettsia rickettsii iinfection by inhibiting activation of apical and effector caspases and maintaining mitochondrial integrity". Infection and Immunity. 2003; . Link
2003
Shammas NW; Pennell BJ; Rossen J; Francis CW; et al. "Evaluation of platelet activation, fibrinolysis and hemostatic activation during high dose dobutamine stress echocardiography". Journal of Angiology. 2003; 12: 162-165. Link
2003
Sahni A; Altland O; Francis CW. "FGF-2 but not FGF-1 binds fibrin and supports prolonged endothelial cell growth". J Thromb Hemost. 2003; 1: 1304-1310. Link
2003
Kaba NK; Francis CW; Hall WJ; Falsey AF; Smith BH. "Protein S declines during winter respiratory infections". J Thromb and Haemost. 2003; 1: 729-732. Link
2003
Colwell CW; Berkowitz SD; Davidson BL; Lotke PA; Francis CW; et al. "Comparison of ximelagatran, an oral direct thrombin inhibitor, with enoxaparin for the prevention of venous thromboembolism following total hip replacement. A randomized, double-blind study". J Thromb Hemost. 2003; 1: 2119-2130. Link
2003
Colwell CW; Francis CW; Berkowitz SE; et al. "Oral direct thrombin inhibitor ximelagatran compared with warfarin for prevention of venous thromboembolism after total knee replacement". J Thromb Haemost. 2003; . Link
2002 Nov
Suchkova VN, Baggs RB, Sahni SK, Francis CW. "Ultrasound improves tissue perfusion in ischemic tissue through a nitric oxide dependent mechanism." Thrombosis and haemostasis. 2002 Nov; 88(5):865-70.
2002 Oct 15
Francis CW, Davidson BL, Berkowitz SD, Lotke PA, Ginsberg JS, Lieberman JR, Webster AK, Whipple JP, Peters GR, Colwell CW. "Ximelagatran versus warfarin for the prevention of venous thromboembolism after total knee arthroplasty. A randomized, double-blind trial." Annals of internal medicine. 2002 Oct 15; 137(8):648-55.
2002 Aug 13
Byrne NP, Henry JC, Herrmann DN, Abdelhalim AN, Shrier DA, Francis CW, Powers JM. "Neuropathologic findings in a Guillain-Barré patient with strokes after IVIg therapy." Neurology. 2002 Aug 13; 59(3):458-61.
2002
Suchkova VN; Carstensen EL; Francis CW. "Ultrasound enhancement of fibrinolysis at frequencies of 27 to 100 kHz". Ultrasound in Med & Biol. 2002; 28: 377-382. Link
2001 Oct 8
Heit JA, Colwell CW, Francis CW, Ginsberg JS, Berkowitz SD, Whipple J, Peters G, . "Comparison of the oral direct thrombin inhibitor ximelagatran with enoxaparin as prophylaxis against venous thromboembolism after total knee replacement: a phase 2 dose-finding study." Archives of internal medicine. 2001 Oct 8; 161(18):2215-21.
2001 May
Anolik JH, Blumberg N, Snider J, Francis CW. "Posttransfusion purpura secondary to an alloantibody reactive with HPA-5a (Br(b))." Transfusion. 2001 May; 41(5):633-6.
2001 Feb
Horan JT, Francis CW, Falsey AR, Kolassa J, Smith BH, Hall WJ. "Prothrombotic changes in hemostatic parameters and C-reactive protein in the elderly with winter acute respiratory tract infections." Thrombosis and haemostasis. 2001 Feb; 85(2):245-9.
2001
Falsey AR; Walsh EE; Francis CW; et al. "Response of C-reactive protein (CRP) and serum amyloid A (SAA) to influenza A infections in older adults". J Infec Dis. 2001; 183: 995-999. Link
2001
Hull RD; Pinieo GF; Stein PD; Mah AF; Francis CW; et al. "Timing of initial administration of low-molecular-weight heparin prophylaxis against deep vein thrombosis in patients following elective hip arthroplasty: a systemic review". Arch Intern Med. 2001; 16: 1852-1960. Link
2000 Sep 12
Bili A, Moss AJ, Francis CW, Zareba W, Watelet LF, Sanz I. "Anticardiolipin antibodies and recurrent coronary events: a prospective study of 1150 patients. Thrombogenic Factors, and Recurrent Coronary Events Investigators." Circulation. 2000 Sep 12; 102(11):1258-63.
2000 Sep
Everbach EC, Francis CW. "Cavitational mechanisms in ultrasound-accelerated thrombolysis at 1 MHz." Ultrasound in medicine & biology. 2000 Sep; 26(7):1153-60.
2000 May 16
Suchkova VN, Baggs RB, Francis CW. "Effect of 40-kHz ultrasound on acute thrombotic ischemia in a rabbit femoral artery thrombosis model: enhancement of thrombolysis and improvement in capillary muscle perfusion." Circulation. 2000 May 16; 101(19):2296-301.
2000 May
Sahni A, Baker CA, Sporn LA, Francis CW. "Fibrinogen and fibrin protect fibroblast growth factor-2 from proteolytic degradation." Thrombosis and haemostasis. 2000 May; 83(5):736-41.
2000
Sahni A, Francis CW. "Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation." Blood. 2000 96(12):3772-8.
2000
Hull R; Pineo G; Francis CW; Bergquist D; et al. "A double-blind, randomized comparison of low-molecular weight heparin prophylaxis using dalteparin extended out of hospital versus warfarin-placebo in hip-arthroplasty patients". Arch Int Med. 2000; 160: 2208-2215. Link
1999 Jul
McCarron BI, Marder VJ, Kanouse JJ, Francis CW. "A soluble fibrin standard: comparable dose-response with immunologic and functional assays." Thrombosis and haemostasis. 1999 Jul; 82(1):145-8.
1999
Francis CW; Pleil AM; Reinhart SP;. "A pharmacoeconomic evaluation of low-molecular-wweight heparin in patients after total hip-replacement surgery". P&T. 1999; 24: 136-145. Link
1998 Sep 8
Suchkova V, Siddiqi FN, Carstensen EL, Dalecki D, Child S, Francis CW. "Enhancement of fibrinolysis with 40-kHz ultrasound." Circulation. 1998 Sep 8; 98(10):1030-5.
1998 Aug
Felcher A, Commichau C, Cao Q, Brown MJ, Torres A, Francis CW. "Disseminated intravascular coagulation and status epilepticus." Neurology. 1998 Aug; 51(2):629-31.
1998 Mar 27
Sahni A, Odrljin T, Francis CW. "Binding of basic fibroblast growth factor to fibrinogen and fibrin." The Journal of biological chemistry. 1998 Mar 27; 273(13):7554-9.
1998 Mar 15
Siddiqi F, Odrljin TM, Fay PJ, Cox C, Francis CW. "Binding of tissue-plasminogen activator to fibrin: effect of ultrasound." Blood. 1998 Mar 15; 91(6):2019-25.
1998 Feb 15
Ryan DH, Crowther MA, Ginsberg JS, Francis CW. "Relation of factor V Leiden genotype to risk for acute deep venous thrombosis after joint replacement surgery." Annals of internal medicine. 1998 Feb 15; 128(4):270-6.
1998
Veklich Y, Francis CW, White J, Weisel JW. "Structural studies of fibrinolysis by electron microscopy." Blood. 1998 92(12):4721-9.
1997 Sep
Francis CW, Pellegrini VD, Totterman S, Boyd AD, Marder VJ, Liebert KM, Stulberg BN, Ayers DC, Rosenberg A, Kessler C, Johanson NA. "Prevention of deep-vein thrombosis after total hip arthroplasty. Comparison of warfarin and dalteparin." The Journal of bone and joint surgery. American volume. 1997 Sep; 79(9):1365-72.
1997 May
Geigel EJ, Francis CW. "Reversal of multiorgan system dysfunction in sickle cell disease with plasma exchange." Acta anaesthesiologica Scandinavica. 1997 May; 41(5):647-50.
1997 Apr
Riggs PN, Francis CW, Bartos SR, Penney DP. "Ultrasound enhancement of rabbit femoral artery thrombolysis." Cardiovascular surgery (London, England). 1997 Apr; 5(2):201-7.
1997 Feb
Illig KA, Green RM, Ouriel K, Riggs PN, Bartos S, Whorf R, DeWeese JA, Chhibber A, Marder VJ, Francis CW. "Primary fibrinolysis during supraceliac aortic clamping." Journal of vascular surgery. 1997 Feb; 25(2):244-51; discussion 252-4.
1997 Jan
Francis CW, Felcher AH, White J, Braaten JV, Goss R. "Thrombin activity associated with indwelling central venous catheters." Thrombosis and haemostasis. 1997 Jan; 77(1):48-52.
1997
Braaten JV; Goss RA; Francis CW. "Ultrasound reversibly disaggregates fibrin fibers". Thrombosis Haemost. 1997; 78: 1063-1068. Link
1997
Everbach EC; Makin IR; Francis CW; et al. "Effect of acoustic cavitation on platelets in the presence of an echo-contrast agent". Ultrasound Med Biol. 1997; 24: 129-136. Link
1997
Dalecki D, Raeman CH, Child SZ, Cox C, Francis CW, Meltzer RS, Carstensen EL. "Hemolysis in vivo from exposure to pulsed ultrasound." Ultrasound in medicine & biology. 1997 23(2):307-13.
1996 Nov 14
Odrljin TM, Rybarczyk BJ, Francis CW, Lawrence SO, Hamaguchi M, Simpson-Haidaris PJ. "Calcium modulates plasmin cleavage of the fibrinogen D fragment gamma chain N-terminus: mapping of monoclonal antibody J88B to a plasmin sensitive domain of the gamma chain." Biochimica et biophysica acta. 1996 Nov 14; 1298(1):69-77.
1996 May
Francis CW, Pellegrini VD, Leibert KM, Totterman S, Azodo MV, Harris CM, Cox C, Marder VJ. "Comparison of two warfarin regimens in the prevention of venous thrombosis following total knee replacement." Thrombosis and haemostasis. 1996 May; 75(5):706-11.
1996
Odrljin TM; Francis CW; Sporn LA; et al. "Heparin binding domain of fibrin mediates its binding to endothelial cells". Arterioscl Thrombosis & Vasc Biol. 1996; 16: 1544-1551. Link
1995 Sep 1
Sporn LA, Bunce LA, Francis CW. "Cell proliferation on fibrin: modulation by fibrinopeptide cleavage." Blood. 1995 Sep 1; 86(5):1802-10.
1995 Mar
Francis CW, Totterman S. "Magnetic resonance imaging of deep vein thrombi correlates with response to thrombolytic therapy." Thrombosis and haemostasis. 1995 Mar; 73(3):386-91.
1995 Mar
Siddiqi F, Blinc A, Braaten J, Francis CW. "Ultrasound increases flow through fibrin gels." Thrombosis and haemostasis. 1995 Mar; 73(3):495-8.
1995
Francis CW, Blinc A, Lee S, Cox C. "Ultrasound accelerates transport of recombinant tissue plasminogen activator into clots." Ultrasound in medicine & biology. 1995 21(3):419-24.
1994 Nov
Shammas NW, Cunningham MJ, Pomerantz RM, Francis CW. "Markers of hemostatic activation in affected coronary arteries during angioplasty." Thrombosis and haemostasis. 1994 Nov; 72(5):672-5.
1994 Aug 15
Hamaguchi M, Bunce LA, Sporn LA, Francis CW. "Plasmic degradation of fibrin rapidly decreases platelet adhesion and spreading." Blood. 1994 Aug 15; 84(4):1143-50.
1994 Jun
Ouriel K, Shortell CK, DeWeese JA, Green RM, Francis CW, Azodo MV, Gutierrez OH, Manzione JV, Cox C, Marder VJ. "A comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral arterial ischemia." Journal of vascular surgery. 1994 Jun; 19(6):1021-30.
1994 May
Harpaz D, Chen X, Francis CW, Meltzer RS. "Ultrasound accelerates urokinase-induced thrombolysis and reperfusion." American heart journal. 1994 May; 127(5):1211-9.
1994 Mar
Blombäck M, Abildgaard U, van den Besselaar AM, Clementson KJ, Dahlbäck B, Exner T, Francis CW, Gaffney P, Gralnick H, Hoyer LW. "Nomenclature of quantities and units in thrombosis and haemostasis (recommendation 1993). A Collaborative project of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis (ISTH/SSC) and the Commission/Committee on Quantities and Units (in Clinical Chemistry) of the International Union of Pure and Applied Chemistry-International Federation of Clinical Chemistry (IUPAC-IFCC/CQU(CC))." Thrombosis and haemostasis. 1994 Mar; 71(3):375-94.
1994
Kashyap A, Blinc A, Marder VJ, Penney DP, Francis CW. "Acceleration of fibrinolysis by ultrasound in a rabbit ear model of small vessel injury." Thrombosis research. 1994 76(5):475-85.
1994
Blinc A; Francis CW; Kennedy SD; et al. "Flow through clots determines the rate and pattern of fibrinolysis". Thrombo Haemost. 1994; 71: 230-235. Link
1994
Onundarson PT; Haraldsson HM; Bermann L; Francis CW; et al. "Onundarson PT; Haraldsson HM; Bermann L; Francis CW; et al". Thromb Haemost. 1994; 70: 998-1004. Link
1993 Oct 15
Lawrence SO, Wright TW, Francis CW, Fay PJ, Haidaris PJ. "Purification and functional characterization of homodimeric gamma B-gamma B fibrinogen from rat plasma." Blood. 1993 Oct 15; 82(8):2406-13.
1993 Oct
Pellegrini VD, Langhans MJ, Totterman S, Marder VJ, Francis CW. "Embolic complications of calf thrombosis following total hip arthroplasty." The Journal of arthroplasty. 1993 Oct; 8(5):449-57.
1993 May 15
Blinc A, Francis CW, Trudnowski JL, Carstensen EL. "Characterization of ultrasound-potentiated fibrinolysis in vitro." Blood. 1993 May 15; 81(10):2636-43.
1993 May 1
Hamaguchi M, Bunce LA, Sporn LA, Francis CW. "Spreading of platelets on fibrin is mediated by the amino terminus of the beta chain including peptide beta 15-42." Blood. 1993 May 1; 81(9):2348-56.
1993 May
Harpaz D, Chen X, Francis CW, Marder VJ, Meltzer RS. "Ultrasound enhancement of thrombolysis and reperfusion in vitro." Journal of the American College of Cardiology. 1993 May; 21(6):1507-11.
1993
Weisel JW, Francis CW, Nagaswami C, Marder VJ. "Determination of the topology of factor XIIIa-induced fibrin gamma-chain cross-links by electron microscopy of ligated fragments." The Journal of biological chemistry. 1993 268(35):26618-24.
1992 Nov
Francis CW, Onundarson PT, Carstensen EL, Blinc A, Meltzer RS, Schwarz K, Marder VJ. "Enhancement of fibrinolysis in vitro by ultrasound." The Journal of clinical investigation. 1992 Nov; 90(5):2063-8.
1992 Aug 1
Kornberg A, Francis CW, Marder VJ. "Plasma crosslinked fibrin polymers: quantitation based on tissue plasminogen activator conversion to D-dimer and measurement in normal and patients with acute thrombotic disorders." Blood. 1992 Aug 1; 80(3):709-17.
1992 Jul
Onundarson PT, Francis CW, Marder VJ. "Depletion of plasminogen in vitro or during thrombolytic therapy limits fibrinolytic potential." The Journal of laboratory and clinical medicine. 1992 Jul; 120(1):120-8.
1992 Jun 3
Francis CW, Pellegrini VD, Marder VJ, Totterman S, Harris CM, Gabriel KR, Azodo MV, Leibert KM. "Comparison of warfarin and external pneumatic compression in prevention of venous thrombosis after total hip replacement." JAMA. 1992 Jun 3; 267(21):2911-5.
1992 May
Marder VJ, Brenner B, Totterman S, Francis CW, Rubin R, Rao AK, Kessler CM, Kwaan HC, Sharma GV, Fong KL. "Comparison of dosage schedules of rt-PA in the treatment of proximal deep vein thrombosis." The Journal of laboratory and clinical medicine. 1992 May; 119(5):485-95.
1992 Mar
Bunce LA, Sporn LA, Francis CW. "Endothelial cell spreading on fibrin requires fibrinopeptide B cleavage and amino acid residues 15-42 of the beta chain." The Journal of clinical investigation. 1992 Mar; 89(3):842-50.
1992 Mar
Owens MR, Ribes JA, Marder VJ, Francis CW. "Effects of ionic and nonionic radiographic contrast agents on endothelial cells in vitro." The Journal of laboratory and clinical medicine. 1992 Mar; 119(3):315-9.
1992
Onundarson PT; Rose JM; Heal JM; Francis CW. "Response to plasma exchange and splenectomy in thrombotic thrombocytopenic purpura: a ten year experience at a single institution." Arch Int Med. 1992; 152: 791-796. Link
1992
Francis CW; Kornberg A. "Fibrinogen and fibrin degradation products during fibrinolytic therapy." Proc New York Acad Sci. 1992; 667: 310-323. Link
1991
Francis CW; Brenner B; Leddy JP; Marder VJ. "Angioedema during therapy with recombinant tissue plasminogen activator". Brit J Hematol. 1991; 77. Link
1990 Jun
Brenner B, Francis CW, Totterman S, Kessler CM, Rao AK, Rubin R, Kwaan HC, Gabriel KR, Marder VJ. "Quantitation of venous clot lysis with the D-dimer immunoassay during fibrinolytic therapy requires correction for soluble fibrin degradation." Circulation. 1990 Jun; 81(6):1818-25.
1990 Apr 1
Ribes JA, Francis CW. "Multimer size dependence of von Willebrand factor binding to crosslinked or noncrosslinked fibrin." Blood. 1990 Apr 1; 75(7):1460-5.
1990 Mar
Mehta RL, Scott G, Sloand JA, Francis CW. "Skin necrosis associated with acquired protein C deficiency in patients with renal failure and calciphylaxis." The American journal of medicine. 1990 Mar; 88(3):252-7.
1990 Jan
Totterman S, Francis CW, Foster TH, Brenner B, Marder VJ, Bryant RG. "Diagnosis of femoropopliteal venous thrombosis with MR imaging: a comparison of four MR pulse sequences." AJR. American journal of roentgenology. 1990 Jan; 154(1):175-8.
1990
Bryant, RG; Marill, K; Blackmore, CC; Francis, CW. "Magnetic relaxation in blood and blood clots". Magnetic Resonance in Med. 1990; 13: 133-144. Link
1990
Francis, CW; Pellegrini, VD; Stulberg, BN; et al. "Prevention of venous thrombosis following total knee arthroplasty". J Bone & Joint Surg. 1990; 72-A: 976-982. Link
1990
Blackmore CC, Francis CW, Bryant RG, Brenner B, Marder VJ. "Magnetic resonance imaging of blood and clots in vitro." Investigative radiology. 1990 25(12):1316-24.
1989 Nov 15
Haidaris PJ, Peerschke EI, Marder VJ, Francis CW. "The C-terminal sequences of the gamma 57.5 chain of human fibrinogen constitute a plasmin sensitive epitope that is exposed in crosslinked fibrin." Blood. 1989 Nov 15; 74(7):2437-44.
1989 Sep 11
Francis CW, Pellegrini VD, Harris CM, Marder VJ. "Antithrombin III prophylaxis of venous thromboembolic disease after total hip or total knee replacement." The American journal of medicine. 1989 Sep 11; 87(3B):61S-66S.
1989 Aug 1
Haidaris PJ, Francis CW, Sporn LA, Arvan DS, Collichio FA, Marder VJ. "Megakaryocyte and hepatocyte origins of human fibrinogen biosynthesis exhibit hepatocyte-specific expression of gamma chain-variant polypeptides." Blood. 1989 Aug 1; 74(2):743-50.
1989 Aug
Ribes JA, Ni F, Wagner DD, Francis CW. "Mediation of fibrin-induced release of von Willebrand factor from cultured endothelial cells by the fibrin beta chain." The Journal of clinical investigation. 1989 Aug; 84(2):435-42.
1989 Jun
Brenner B, Francis CW, Marder VJ. "The role of soluble cross-linked fibrin in D dimer immunoreactivity of plasmic digests." The Journal of laboratory and clinical medicine. 1989 Jun; 113(6):682-8.
1989 May 15
Brenner B, Francis CW, Fitzpatrick PG, Rothbard RL, Cox C, Hackworthy RA, Anderson JL, Sorensen SG, Marder VJ. "Relation of plasma D-dimer concentrations to coronary artery reperfusion before and after thrombolytic treatment in patients with acute myocardial infarction." The American journal of cardiology. 1989 May 15; 63(17):1179-84.
1989 Mar
Francis CW, Doughney K, Brenner B, Klingbiel K, Marder VJ. "Increased immunoreactivity of plasma after fibrinolytic activation in an anti-DD ELISA system. Role of soluble crosslinked fibrin polymers." Circulation. 1989 Mar; 79(3):666-73.
1989 Mar
Francis CW, Pellegrini VD, Marder VJ, Harris CM, Totterman S, Gabriel KR, Baughman DJ, Roemer S, Burke J, Goodman TL. "Prevention of venous thrombosis after total hip arthroplasty. Antithrombin III and low-dose heparin compared with dextran 40." The Journal of bone and joint surgery. American volume. 1989 Mar; 71(3):327-35.
1989
Francis, CW; Foster, TH; Totterman, S; et al. "Monitoring of therapy for deep vein thrombosis using magnetic resonance imaging". Acta Radiologica. 1989; 4: 445-446. Link
1989
Stulberg, BN; Francis, CW; Pellegrini, VD; et al. "Antithrombin III/low dose heparin in the prevention of deep-vein thrombosis following total knee arthroplasty". Clin Ortho Rel Res. 1989; 248: 152-157. Link
1988 May
Francis CW, Marder VJ. "Increased resistance to plasmic degradation of fibrin with highly crosslinked alpha-polymer chains formed at high factor XIII concentrations." Blood. 1988 May; 71(5):1361-5.
1988 May
Francis CW, Müller E, Henschen A, Simpson PJ, Marder VJ. "Carboxyl-terminal amino acid sequences of two variant forms of the gamma chain of human plasma fibrinogen." Proceedings of the National Academy of Sciences of the United States of America. 1988 May; 85(10):3358-62.
1988 Feb
Woodlock TJ, Francis CW, Rowe JM, Brown MJ, Marder VJ. "Prolonged remission after life-threatening gastrointestinal hemorrhage from coexistent angiodysplasia and acquired bleeding diathesis." American journal of hematology. 1988 Feb; 27(2):125-31.
1988
Francis, CW; Ricotta, JJ; Evarts, CM; Marder, VJ. "Long term clinical findings and venous functional abnormalities after asymptomatic total hip and knee replacement". Clin Orth Rel Res. 1988; 232: 271-278. Link
1987 Nov
Francis CW, Marder VJ. "Rapid formation of large molecular weight alpha-polymers in cross-linked fibrin induced by high factor XIII concentrations. Role of platelet factor XIII." The Journal of clinical investigation. 1987 Nov; 80(5):1459-65.
1987 Jun
Francis CW, Connaghan DG, Scott WL, Marder VJ. "Increased plasma concentration of cross-linked fibrin polymers in acute myocardial infarction." Circulation. 1987 Jun; 75(6):1170-7.
1987 Jan
Ribes JA, Francis CW, Wagner DD. "Fibrin induces release of von Willebrand factor from endothelial cells." The Journal of clinical investigation. 1987 Jan; 79(1):117-23.
1987
Marder, VJ; Francis, CW. "Two-step warfarin therapy for the prophylaxis of venous thrombosis after elective surgery". Avd Exp Med Biol. 1987; 214: 159-163. Link
1986 Nov
Francis CW, Connaghan DG, Marder VJ. "Assessment of fibrin degradation products during fibrinolytic therapy for acute myocardial infarction." Circulation. 1986 Nov; 74(5):1027-36.
1986 Sep
Connaghan DG, Francis CW, Ryan DH, Marder VJ. "Prevalence and clinical implications of heparin-associated false positive tests for serum fibrin(ogen) degradation products." American journal of clinical pathology. 1986 Sep; 86(3):304-10.
1986 Jun
Scott WL, Francis CW, Knutson DW, Marder VJ. "Specific identification of urinary fibrinogen, fibrinogen degradation products, and cross-linked fibrin degradation products in renal diseases and after renal allotransplantation." The Journal of laboratory and clinical medicine. 1986 Jun; 107(6):534-43.
1986 Apr 5
Francis CW, Marder VJ, Evarts CM. "Lower risk of thromboembolic disease after total hip replacement with non-cemented than with cemented prostheses." Lancet. 1986 Apr 5; 1(8484):769-71.
1986 Mar
Marder VJ, Rothbard RL, Fitzpatrick PG, Francis CW. "Rapid lysis of coronary artery thrombi with anisoylated plasminogen: streptokinase activator complex. Treatment by bolus intravenous injection." Annals of internal medicine. 1986 Mar; 104(3):304-10.
1986 Feb
Peerschke EI, Francis CW, Marder VJ. "Fibrinogen binding to human blood platelets: effect of gamma chain carboxyterminal structure and length." Blood. 1986 Feb; 67(2):385-90.
1986
Francis, CW; Marder, VJ. "Degradation of crosslinked fibrin by human leukocyte proteases". J Lab Clin Med. 1986; 107. Link
1985 Oct
Rowe JM, Francis CW, Cyran EM, Marder VJ. "Thrombotic thrombocytopenic purpura: recovery after splenectomy associated with persistence of abnormally large von Willebrand factor multimers." American journal of hematology. 1985 Oct; 20(2):161-8.
1985 Mar
Connaghan DG, Francis CW, Lane DA, Marder VJ. "Specific identification of fibrin polymers, fibrinogen degradation products, and crosslinked fibrin degradation products in plasma and serum with a new sensitive technique." Blood. 1985 Mar; 65(3):589-97.
1985 Mar
Rothbard RL, Fitzpatrick PG, Francis CW, Caton DM, Hood WB, Marder VJ. "Relationship of the lytic state to successful reperfusion with standard- and low-dose intracoronary streptokinase." Circulation. 1985 Mar; 71(3):562-70.
1985
Francis CW, Malone JE, Marder VJ. "Comparison of a chromogenic prothrombin time with clotting prothrombin time in the assessment of clinical coagulation deficiencies." American journal of clinical pathology. 1985 84(6):724-9.
1984 Nov
Marder VJ, Francis CW. "Thrombolytic therapy for acute transmural myocardial infarction. Intracoronary versus intravenous." The American journal of medicine. 1984 Nov; 77(5):921-8.
1984 Sep 25
Hanna LS, Scheraga HA, Francis CW, Marder VJ. "Comparison of structures of various human fibrinogens and a derivative thereof by a study of the kinetics of release of fibrinopeptides." Biochemistry. 1984 Sep 25; 23(20):4681-7.
1984 May
Francis CW, Markham RE, Marder VJ. "Demonstration of in situ fibrin degradation in pathologic thrombi." Blood. 1984 May; 63(5):1216-24.
1984 Mar 1
Francis CW, Keele EM, Marder VJ. "Purification of three gamma-chains with different molecular weights from normal human plasma fibrinogen." Biochimica et biophysica acta. 1984 Mar 1; 797(3):328-35.
1984 Feb 28
Francis CW, Nachman RL, Marder VJ. "Plasma and platelet fibrinogen differ in gamma chain content." Thrombosis and haemostasis. 1984 Feb 28; 51(1):84-8.
1983 Aug
Francis CW, Markham RE, Barlow GH, Florack TM, Dobrzynski DM, Marder VJ. "Thrombin activity of fibrin thrombi and soluble plasmic derivatives." The Journal of laboratory and clinical medicine. 1983 Aug; 102(2):220-30.
1983 Jun 27
Marder VJ, Francis CW. "Plasmin degradation of cross-linked fibrin." Annals of the New York Academy of Sciences. 1983 Jun 27; 408:397-406.
1983 Jun 27
Francis CW, Marder VJ. "Heterogeneity of normal human fibrinogen due to two high molecular weight variant gamma chains." Annals of the New York Academy of Sciences. 1983 Jun 27; 408:118-20.
1983 Apr 28
Francis CW, Kraus DH, Marder VJ. "Structural and chromatographic heterogeneity of normal plasma fibrinogen associated with the presence of three gamma-chain types with distinct molecular weights." Biochimica et biophysica acta. 1983 Apr 28; 744(2):155-64.
1983 Jan 21
Francis CW, Marder VJ, Evarts CM, Yaukoolbodi S. "Two-step warfarin therapy. Prevention of postoperative venous thrombosis without excessive bleeding." JAMA. 1983 Jan 21; 249(3):374-8.
1983
Martin, SE; Francis, CW; Marder, VJ. "Potentiation of wheat germ aggultinin aggregation of platelets by von Willebrand protein and by a 116,000 molecular weight tryptic fragment". Thromb Res. 1983; 31: 437-449. Link
1981 Sep 15
Barlow GH, Francis CW, Marder VJ. "On the conversion of high molecular weight urokinase to the low molecular weight form by plasmin." Thrombosis research. 1981 Sep 15; 23(6):541-7.
1981 Feb
Martin SE, Marder VJ, Francis CW, Barlow GH. "Structural studies of the functional heterogeneity of von Willebrand protein polymers." Blood. 1981 Feb; 57(2):313-23.
1981
Francis, CW; Marder, VJ. "A molecular model of plasmic degradation of crosslinked fibrin". Sem Thromb Haemost. 1981; : 25-35. Link
1980 Nov
Francis CW, Marder VJ, Barlow GH. "Plasmic degradation of crosslinked fibrin. Characterization of new macromolecular soluble complexes and a model of their structure." The Journal of clinical investigation. 1980 Nov; 66(5):1033-43.
1980 Sep
Francis CW, Marder VJ, Martin SE. "Plasmic degradation of crosslinked fibrin. I. Structural analysis of the particulate clot and identification of new macromolecular-soluble complexes." Blood. 1980 Sep; 56(3):456-64.
1980 Jun 25
Francis CW, Marder VJ, Martin SE. "Demonstration of a large molecular weight variant of the gamma chain of normal human plasma fibrinogen." The Journal of biological chemistry. 1980 Jun 25; 255(12):5599-604.
1980 May
Martin SE, Marder VJ, Francis CW, Loftus LS, Barlow GH. "Enzymatic degradation of the factor-VIII-von-Willebrand protein: a unique tryptic fragment with ristocetin cofactor activity." Blood. 1980 May; 55(5):848-58.
1979
Francis CW, Marder VJ, Martin SE. "Detection of circulating crosslinked fibrin derivatives by a heat extraction-SDS gradient gel electrophoretic technique." Blood. 1979 54(6):1282-95.
0
Colwell CW; Berkowitz SD; Davidson BL; Lotke PA; Ginsberg JS; Francis CW. "Comparison of ximelegatran, an oral direct thrombin inhibitor, with enoxaparin for the prevention of venous thromboembolism following total hip replacement." J Thromb Hemost. . Link
0
Khorana AA; Sahni A; Altland OD; Francis CW. "Heparin inhhibition of endothelial cell proliferation and organization is dependent on nolecular weight". Arterioscler Thromb Vasc Biol. . Link
0
Peng H; Sahni A; Fay P; Bellum S; Prudosky I; Maciag T; Francis CW. "Identification of a binding site on human FGF-2 for fibrinogen". Blood. . Link
0
Francis CW; Berkowitz SD; Comp PC. "Comparison of the Oral Direct Thrombin Inhibitor Ximelagatran with Warfarin for the Prevention of Venous Thromboembolism Following Total Knee Replacement: EXULT A. N." N. Eng. J. Med. . Link
0
Altand OD; Dalecki D; Suchkova VN; Francis CW. "Low-intensity ultrasound increases endothelial cell nitric oxide synthase activity and nitric oxide synthase activity and nitric oxide synthesis". J Thromb Haemost. . Link
0
Kaba NK; Francis CW; Moss AJ; Zareba W; Oakes D; Knox KL; Fernandez ID; et al. "Effects of lipids and lipid-lowering therapy on hemostatic factors in patients with myocardial infarction". J Thromb Haemost. . Link
0
Joshi SG; Francis CW; Silverman DJ; Sahni SK. "NF-kB activation suppresses host cell apoptosis during Rickettsia rickettsii infection via regulatory effects on intracellular localization or levels of apoptogenic and antiapoptotic proteins." FEMS Microbiology Letters. . Link
0
Sahni A; Guo M; Sahni SK; Francis CW. "Interluekin-1B but not IL-1a Binds t Fibrinogen and Fibrin and has Enhanced Activity in the Bound form." Blood. . Link
0
Moss AJ; Ryan D; Oakes D; Goldstein RE; Greenberg H; Bodenheimer MM; Brown MW; Case RB; Francis CW; et al. "Coronary disease-related risk genotypes and reduction in recurrent coronary events after myocardial infarction". JACC. . Link
0
Komrokji RS; Uppal NP; Khorana AA; Lyman GH; Kaplan KK; Fisher RI; Francis CW. "Venous thromboembolism in patients with diffuse large B cell lymphoma". Leukemia and Lymphoma. . Link
0
O'Brien JJ; Baglole CJ; Garcia-Bates TM; Blumberg N; Francis CW, Phipps RP. "15-deoxy-(delta)12, 14 prostaglandin J2-induced heme oxygenase-1 in megakaryocytes regulates thrombopoiesis". Thromb Haemost. .
0
. "Venous Thromboembolism Prophylaxis and Treatment in Patients with Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.".

Books

2006
Francis CW; Kaplan K. "Venous and arterial thrombosis". Clinical Hematology. : MOSBY Elsevier, 2006.
2006
Francis CW; Marder VJ. "Clinical disorders of fibrinolysis". Hemostasis and Thrombosis: Basic Prin. & Clinical Prac.. : Lippincott Wlliams & Wilkins, 2006.
2005
Francis CW; Marder VJ. "Physiologic regulation and patholoogic disorders of fibrinolysis". Hemostasis & Thrombosis: Basic Prin. & Clin. Prac.. : Lippincott Williams & Wilkens, 2005.
2005
Francis CW; Kaplan K. "Principles of Anticoagulant Therapy". Williams Hematology 7th Ed.. : McGraw Hill, 2005.
2005
Hajjar KA; Francis CW. "Fibrinolysis and Thrombolysis". Williams Hematology. : McGraw Hill, 2005.
2005
Rao, MN; Francis, CW; Khorana, AA.. "Who's at risk for VTE? Strategies for risk stratifying cancer patients.". New Findings in Cancer-associated Thrombosis. : Informa Healthcare, 2005.
2004
Francis CW. "Ximelagatran: a new oral anticoagulant". Best Practice & Research Clinical Hematology. : Elsevier Ltd., 2004.
2003
Francis CW; Suchkova VN. "Thrombolysis and Ultrasound". New Therapeutic Agents in Thrombosis and Thrombolysis. : Marcel Dekker, Inc., 2003.
2003
Francis CW. "Prevention and Treatment of Venous Thromboembolic Disease". Thrombosis and Hemorrhage. : Lippincott Williams & Wilkins, 2003.
2001
Hantgan RR; Simpson-Haidaris PJ; Francis CW; et al. Hemostasis and Thrombosis: Basic Principles and Clin. Prac.. : Lippincott-Raven, 2001.
2001
Francis CW; Marder VJ. "Physiologic regulation and pathologic disorders of fibrinolysis". Hemostasis and Thrombosis: Basic Princ. and Clin. Prac.. : Lippincott-Raven, 2001.
1995
Francis CW. "The fibrinolytic system: Physiology and Pathophysiology". Thrombolytic Therapy for Peripheral Vascular Disease. : J. B. Lippincott, 1995.
1995
Francis CW. "Hematology problems in the surgical patient: Bleeding and Thrombosis". Hematology: Basic Principles and Practice, 2nd ed.. : Churchill Livingstone, 1995.
1991
Francis CW. "Hematologic problems in the surgical patient: Bleeding and Thrombosis". Hematology. Basic principles and Practice. : Churchill Livingstone, 1991.
1987
Hantgan RR; Francis CW; et al. "Fibrinogen structure and physiology". Hemostasis and Thrombosis. : J. B. Lippincott, 1987.
1987
Marder VJ; Martin SE; Francis CW; et al. "Consumptive thrombohemorrhagic disorders". Hemostasis and Thrombosis. : J. B. Lippincott, 1987.
1982
Marder VJ; Francis CW; Doolittle RF. "Fibrinogen structure and physiology". Hemostasis and Thrombosis: Basic principles and clinical prac. : JB Lippincott Co., 1982.